TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Science Policy: All’s Well In Access to Trials, GAO Study Finds; NIH Disagrees November 5, 1999
TCL Archive In Brief: Gifts to NCI Totaled $332,226 In Fiscal 1986; Position Freeze Said To Hurt DCE Labs January 3, 1986
